Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway
about
Polymorphisms and expression pattern of circular RNA circ-ITCH contributes to the carcinogenesis of hepatocellular carcinoma.MiR-101 inhibits ovarian carcinogenesis by repressing the expression of brain-derived neurotrophic factor.Long non-coding RNAs associated with non-small cell lung cancer.Long non-coding RNA TUG1 promotes cervical cancer progression by regulating the miR-138-5p-SIRT1 axis.Long non-coding RNA NEAT1 regulates epithelial membrane protein 2 expression to repress nasopharyngeal carcinoma migration and irradiation-resistance through miR-101-3p as a competing endogenous RNA mechanism.LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR-509-5p to modulate FOXP1 expression.lncTCF7 is a negative prognostic factor, and knockdown of lncTCF7 inhibits migration, proliferation and tumorigenicity in glioma.LncRNA XIST acts as a tumor suppressor in prostate cancer through sponging miR-23a to modulate RKIP expression.Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes.Integrated genomic analyses of lung squamous cell carcinoma for identification of a possible competitive endogenous RNA network by means of TCGA datasets.Co-expression analysis revealed PTCH1-3'UTR promoted cell migration and invasion by activating miR-101-3p/SLC39A6 axis in non-small cell lung cancer: implicating the novel function of PTCH1.LncRNAs regulate cancer metastasis via binding to functional proteins.Up-regulation of lncRNA SNHG1 indicates poor prognosis and promotes cell proliferation and metastasis of colorectal cancer by activation of the Wnt/β-catenin signaling pathway.lncRNA SNHG5 is associated with poor prognosis of bladder cancer and promotes bladder cancer cell proliferation through targeting p27.SNHG1 promotes cell proliferation by acting as a sponge of miR-145 in colorectal cancer.Hiding in Plain Sight: Rediscovering the Importance of Noncoding RNA in Human Malignancy.Long non-coding RNAs function as novel predictors and targets of non-small cell lung cancer: a systematic review and meta-analysis.An integromic signature for lung cancer early detection.High lncRNA HULC expression is associated with poor prognosis and promotes tumor progression by regulating epithelial-mesenchymal transition in prostate cancer.Long Noncoding RNA Small Nucleolar RNA Host Gene 1 (SNHG1) Promotes Renal Cell Carcinoma Progression and Metastasis by Negatively Regulating miR-137.Bibliometric Analysis of Global Scientific Research on lncRNA: A Swiftly Expanding Trend.SNHG8 is identified as a key regulator in non-small-cell lung cancer progression sponging to miR-542-3p by targeting CCND1/CDK6Long non-coding RNA SNHG1 predicts a poor prognosis and promotes colon cancer tumorigenesisLncRNA myocardial infarction-associated transcript promotes cell proliferation and inhibits cell apoptosis by targeting miR-330-5p in epithelial ovarian cancer cellsA Plasma Long Noncoding RNA Signature for Early Detection of Lung CancerThe Prognostic Value of Expression of the Long Noncoding RNA (lncRNA) Small Nucleolar RNA Host Gene 1 (SNHG1) in Patients with Solid Malignant Tumors: A Systematic Review and Meta-Analysis
P2860
Q40163580-C5D34DD2-5AC9-48B0-834D-8775A9923233Q41627612-D9BF53DD-D2EE-4352-ABF3-366D8793E363Q42366666-C5629AF8-7118-4921-97D4-4FA549608E36Q42371523-C6646335-E374-4F6A-861A-FBD6170A8D1BQ42378413-F128E0B6-83C2-4902-AEF2-256AADA01DD6Q47120655-AFA4DC03-F5F8-4EB2-93D3-C7E4A5489F5CQ47133782-F96EF047-A891-437E-B508-BA45D0D09FB5Q47145939-7DA225D3-B6F8-49AF-93F6-217BA0A61F43Q47394844-E89DC13B-3465-4C5E-9AB7-03A8170D3DF1Q48231139-A3012EE6-C67F-453F-97E5-8985676196D7Q49613127-7DD5FB7A-D84E-49CB-AB86-E4610D49E461Q49740926-1881D743-4B6B-4D07-9289-13F397DFAB8EQ49776952-68C0EEC1-2702-4AEB-8AE7-5C29C3FE82ECQ49880961-F32CD43D-11CD-464B-9925-23A86E5AE272Q50127990-851A3CF4-4E14-4654-B57B-537B423F78A2Q52597886-F31BFC57-3850-455E-8650-AC94E98D5D18Q52655034-D56DF12A-D5E3-4425-B6B5-427F8AFEC8E1Q55074632-D444661A-A846-4971-8DEE-29886835BDA6Q55216970-D242D6BB-934C-47C0-A203-F1E28AD2F1CAQ55381081-3E3D0B5F-F6A3-4532-BFB7-3E713459A5B9Q55476405-93EF9276-6269-4E75-8D41-B5E568AF06C2Q57072200-9378C247-8B4D-42BC-B160-92F5DCB530C7Q57178789-A81B750C-BC2C-45E8-817C-2D9E36D9FED8Q58588559-7484625F-02B4-462D-85DC-B394D5888842Q58795598-DEE05013-FCDA-4A5F-A1FC-A934789014D5Q58798862-01C0F800-73E2-4F19-9AA2-31B1E1B03EED
P2860
Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Upregulated lncRNA SNHG1 contr ...... nt/β-catenin signaling pathway
@ast
Upregulated lncRNA SNHG1 contr ...... nt/β-catenin signaling pathway
@en
Upregulated lncRNA SNHG1 contr ...... t/β-catenin signaling pathway.
@nl
type
label
Upregulated lncRNA SNHG1 contr ...... nt/β-catenin signaling pathway
@ast
Upregulated lncRNA SNHG1 contr ...... nt/β-catenin signaling pathway
@en
Upregulated lncRNA SNHG1 contr ...... t/β-catenin signaling pathway.
@nl
prefLabel
Upregulated lncRNA SNHG1 contr ...... nt/β-catenin signaling pathway
@ast
Upregulated lncRNA SNHG1 contr ...... nt/β-catenin signaling pathway
@en
Upregulated lncRNA SNHG1 contr ...... t/β-catenin signaling pathway.
@nl
P2093
P2860
P356
P1433
P1476
Upregulated lncRNA SNHG1 contr ...... nt/β-catenin signaling pathway
@en
P2093
Chunkai Zhu
Fuming Zhang
Huaimin Liu
Liang Geng
Tongde Tian
P2860
P304
17785-17794
P356
10.18632/ONCOTARGET.14854
P407
P577
2017-01-27T00:00:00Z